BIOMAT Database Logo BIOMAT Database Logo

Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists. 2004

Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. kinoyama@yamanouchi.co.jp

The search for novel antiandrogens by high-throughput screening (HTS) of the Yamanouchi chemical library led to the discovery of the lead compound (5), which possesses an arylmorpholine moiety. Through the optimization of the lead compound (5), we have found a series of novel arylpiperazine derivatives. Among them, 4-[4-cyano-(3-trifluoromethyl)phenyl]-N-(4-fluorophenyl)piperazine-1-carboxamide (22; YM-92088) exhibited a potent AR antagonistic activity with an IC(50) value of 0.47 microM in the reporter assay, which is more potent than bicalutamide (4) which has an IC(50) value of 0.89 microM.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO
D059002 Androgen Receptor Antagonists Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. Androgen Receptor Antagonist,Antagonist, Androgen Receptor,Antagonists, Androgen Receptor,Receptor Antagonist, Androgen,Receptor Antagonists, Androgen

Related Publications

Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and pharmacological evaluation of indolinone derivatives as novel ghrelin receptor antagonists.
September 2012, Bioorganic & medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and pharmacological evaluation of novel arylpiperazine oxicams derivatives as potent analgesics without ulcerogenicity.
April 2019, Bioorganic & medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists.
January 2012, Bioorganic & medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists.
June 2015, Journal of medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents.
January 2017, Anti-cancer agents in medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.
January 2022, Frontiers in chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
October 2014, Archiv der Pharmazie,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists.
June 2015, European journal of medicinal chemistry,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists.
October 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Isao Kinoyama, and Nobuaki Taniguchi, and Toru Yoden, and Hiroshi Koutoku, and Takashi Furutani, and Masafumi Kudoh, and Minoru Okada
Synthesis and pharmacological evaluation of novel fused thiophene derivatives as 5-HT2A receptor antagonists: molecular modeling study.
May 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!